Key result
Methylglyoxal-induced glycation stress increased aortic pulse wave velocity in young mice by 21% (414 vs 342 cm/sec, P=0.03), an effect that was prevented by the glycation-lowering compound Gly-Low.
Why the study?
The role of methylglyoxal and its non-crosslinking AGE MGH-1 in aortic stiffening, and the potential of the glycation stress-lowering compound Gly-Low to mitigate these effects, was unknown.
Does Gly-Low prevent methylglyoxal-induced and age-related aortic stiffening in mice?
Population
Young (3-6 month) and old (24 month) C57BL/6 mice, aortic tissue, and cultured HAECs
Comparison
MGO, Gly-Low, or MGO plus Gly-Low vs controls
Design
Preclinical animal and cell-culture experimental study
Authors
Loading...
Hypothesis-generating for glycation-lowering in aortic stiffness; human trials required before any clinical consideration.
Does Gly-Low prevent methylglyoxal-induced and age-related aortic stiffening in mice?
Effect estimate: 21% increase
Absolute Event Rate: 414% vs 342%
p-value: p=0.03
Glycation-lowering compounds like Gly-Low can mitigate methylglyoxal-induced and age-related aortic stiffening by reducing oxidative stress and cellular senescence.
Singh et al. (2025) studied Aortic stiffening and glycation stress. Methylglyoxal (MGO) and Gly-Low vs. Standard water and chow was evaluated on Aortic pulse wave velocity (PWV) (21% increase, p=0.03). Methylglyoxal-induced glycation stress increased aortic pulse wave velocity in young mice by 21% (414 vs 342 cm/sec, P=0.03), an effect that was prevented by the glycation-lowering compound Gly-Low.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: